Coronavirus y lupus

• 24 de marzo de 2020 - El Coronavirus, el Estrés y la Salud Mental
• 23 de marzo de 2020 - Preguntas y respuestas sobre la Hidroxicloroquina (Plaquenil) y el Coronavirus (COVID-19)
• 20 de marzo de 2020 - Actualización de Coronavirus: Acceso a Hidroxicloroquina (Plaquenil) para personas con lupus
• 17 de marzo de 2020 - Los Centros de Control y Prevención de Enfermedades (CDC, por sus siglas en inglés) han recomendado que las personas con enfermedades subyacentes graves se queden en casa y eviten a otras personas tanto como sea posible hasta el 30 de marzo de 2020. El lupus es una enfermedad subyacente grave que podría conducir a un sistema inmunitario comprometido.
  
  Consulte el Apéndice A (en la página 10) en este documento de los CDC  (en inglés) para obtener una explicación más detallada de las condiciones de salud subyacentes que pueden aumentar el riesgo de enfermedad grave por coronavirus.
  
  Para más información en Español visite: www.cdc.gov/coronavirus/2019-ncov/index-sp.html

Some of our chapters have been posting more local information for the people with lupus in their regions. Follow the links below to their coronavirus-related pages, or find your region or chapter.

• Florida
• Heartland (Missouri, Southern Illinois, & Eastern Kansas)
• Philadelphia Tri-State (Delaware, New Jersey and Southern Pennsylvania)
• Texas Gulf Coast

• March 15: We have two new videos from Dr. Ashira Blazer on COVID-19 and lupus. The first video is a panel presentation on the impact of COVID-19 on people with lupus and an overview of COVID-19 vaccines. In the second video, Dr. Blazer answers questions from people with lupus about the COVID-19 vaccines.
• December 6 - In a Virtual Town Hall with the Georgia Chapter, Dr. Sam Lim discussed what the COVID-19 vaccine applications means for people living with lupus. Watch now.
• October 26: Dr. Karen Costenbader provides an update on the impact of COVID-19, including how to distinguish between a lupus flare and COVID-19 symptoms, and information on vaccines and the flu shot for people with lupus.
• July 13: Dr. Karen Costenbader, Director of the Lupus Program at Brigham & Women's Hospital in Boston, answers questions about the coronavirus and lupus, and precautions and considerations to take as state's enter different phases of reopening.
• July 10: Dr. Tamar Rubinstein, Assistant Professor of Pediatric Rheumatology, Children’s Hospital at Montefiore answers some common questions about children living with lupus amid the coronavirus – including considerations to take if schools open, when socializing with friends and easing stress.
• April 15: Dr. Sam Lim, Chief of Rheumatology for Grady Health System in Atlanta, Georgia, provides an update about the COVID-19 pandemic and its impact on people with lupus.
• April 9: Travis Smith, Director of Government Relations for the Lupus Foundation of America, updates recent efforts to expand the supply and access to hydroxchloroquine and choloroqine for people with lupus
• April 1: Pat Wildman, Lupus Foundation of America Vice President for Advocacy & Government Relations, gives a status report on our actions to date to ensure a supply of hydroxychloroquine for people with lupus.
• March 28: Dr. Ashira Blazer gives an update about the coronavirus and its impact on people with lupus
• March 20: Dr. Ashira Blazer, Assistant Professor of Medicine in the Division of Rheumatology at New York University's Langone Medical Center, provides initial information about the coronavirus and its impact on people with lupus.